
Ezetimibe - Impurity BCAS 163380-16-3
- Catalogue No.
- CSL-15753
- Alternative Cat. No.
- E975010
- CAS No.
- 163380-16-3
- Molecular formula
- C24H21F2NO3
- Molecular weight
- 409.43
- Parent drug
- Ezetimibe
- Product type
- Impurities, Pharmaceutical Reference Standards, Other, Intermediates and building blocks, pharmaceutical standards, Fine Chemicals, aromatics, Heterocycles, amines, fluorescent labels and indicators, drug analogues
Quick quote · CSL-15753Price and availability on request
ISO 17034:2016 · GLPTell us the quantity you need, from a few milligrams upwards, and we reply within 24 hours with price, availability and delivery time.
Need documents or a larger lot? Use the full quote form
Synonyms
- (3R,4S)-1-(4-fluorophenyl)-3-[(3R)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one
- Ezetimibe (3'R)-Isomer
- (3'R)-Ezetimibe
Show all 12 synonyms
- (3'R, 3R, 4S)-Ezetimibe
- (3R, 4S, 3'R)-Ezetimibe
- (3R,4S)-1-(4-Fluorophenyl)-3-((R)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one
- (3R,4S)-1-(4-Fluorophenyl)-3-[(3R)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone
- [3R-[3α(R*),4α]]-1-(4-Fluorophenyl)-3-[3-(4-fluorophenyl)-3- hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone
- R,R,S-Ezetimibe (USP)
- (3’R)-Ezetimibe
- RRS-Ezetimibe
- (3R)-Ezetimibe
More Ezetimibe products
All 327 →![Chemical structure of ((4R)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F404874-94-8-4R-3-5S-5-4-Fluorophenyl-5-hydroxypentanoyl-4-phenyl-13-oxazolidin-2-one.png&w=3840&q=75)
((4R)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one)404874-94-8

(2R,3R,6S)-6-(4-Fluorophenyl)-2-(4-hydroxyphenyl)tetrahydro-2H-pyran-3-carboxylic Acid1618657-31-0

(2R,5S)-2-(4-Hydroxybenzyl)-N,5-bis(4-fluorophenyl)-5-hydroxypentanamide1197811-72-5

(2R,5S)-N,5-Bis(4-fluorophenyl)-5-hydroxy-2-((4-hydroxycyclohexa-2,5-dien-1-ylidene)methyl)-N-nitrosopentanamideCSL-197755

